Medical Device News Magazine

2022 Heatwave Struck Off Surgery in Fifth of UK Hospitals

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The 2022 summer heatwave resulted in a fifth of UK hospitals being forced to cancel operations during the three days when temperatures soared, a new study reveals.

Had the high temperatures continued, a further third of hospitals would have had to cancel surgery, as NHS buildings are not set up to withstand dangerously high temperatures.

The team surveyed surgeons, anaesthetists, and critical care doctors working during the heatwave of 16 – 19 July 2022.

They received 271 responses from 140 UK hospitals with one in five respondents (18.5%) reporting the heatwave resulted in elective surgery being cancelled. A further third (35.1%) anticipated that cancellations would have been likely had the heatwave continued.

Factors contributing to heatwave-related cancellations included staff shortages (35.8% of respondents), unsafe theatre environments (30.3%), and bed shortages (22.1%).

Surgical services were poorly prepared for heatwaves with ambient temperature uncontrollable in 41.0% of operating theatres. Most hospitals which responded (85%) lacked ‘summer pressure’ plans to maintain elective surgical safety and capacity. Over a third of respondents (35.4%) reported making adaptations to maintain the routine surgical activity during the heatwave.

Co-author Mr James Glasbey, NIHR Doctoral Research Fellow in Global Surgery at the University of Birmingham, commented: “Even short heatwaves may result in widespread disruption to surgical services in the UK. The likelihood of extreme weather events is growing – we could find ourselves in both a ‘winter’ and ‘summer’ stress situation within the next few years.

“As hospitals tackle post-COVID surgery backlogs, they must consider how to safeguard against further climate change-related disruption to the delivery of surgical services. This should be included in the preparation of ‘summer pressure’ plans to improve the resilience of elective surgery services.”

Supported by a National Institute for Health Research (NIHR) Global Health Research Unit Grant, the GreenSurg Collaborative, led by researchers at the University of Birmingham, published their findings in a letter to British Journal of Surgery.

The researchers discovered that hospitals adopted several strategies during the heatwave to cushion the impact of rising temperatures on surgical patients. These included delayed discharge of high-risk patients, changes to surgical teams, selecting lower risk patients to have surgery, and restricting surgical activity to day-cases.

Some hospitals also introduced longer staff breaks, gave extra fluids to patients admitted, and started surgeries earlier in the morning when temperatures were lower.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”